PPT-FMD progress update Implementing the EU Falsified Medicines Directive in the UK

INSERT DATE HERE NAME OF PRESENTER TITLE OF PRESENTER COMPANY NAME 2 FMD timeline and concept Falsified Medicines Directive FMD timeline 4 2011 2013 2015 2016 2019 2024 Directive 201162EU adopted. Medicines are now the second largest categor y of falsified items imported into Europe ZKHUHDV57347WKH57347GLGQ57526W57347ZDUUDQW57347D57347VHSDUDWH57347FDWHJRU57347LQ 004 because numbers were so low The chart below displays an increasing trend in i Progress Update on the Sunpower 35W Stirling Convertor J. Gary Wood and Neill W. Lane Sunpower, Inc., Athens, Ohio 45701 This paper reports on progress in the development of a highly efficiency low ma PT. Falsified Medicines. R. esponding . E. ffectively to the . P. roduction of and . T. rafficking in Falsified Medicines. Law Enforcement Training on Falsified Medicines. Accra (Ghana), October 6, 2015. Bright MLS Update. The Bright Vision. 3. The Bright Vision. Bright MLS wants to empower everyone to get more out of the MLS.. 4. Broker Centric. Broader Listing Coverage. MLS Simplified. Reduced Technology Costs. Meeting of the Parties to the Protocol on Pollutant Release and Transfer Registers to the Convention on Access to Information, Public Participation in Decision-making and Access to Justice in Environmental Matters. . Leyla Hannbeck . MRPharmS, MBA, MSc, MA. NPA Chief Pharmacist and Director of Pharmacy. Falsified medicines: the facts. Falsified medicines may:. Be fraudulently mislabelled. Contain low quality ingredients. Nicholas Falzon – PRIMA President. Definition of . a Falsified . Medicine. According to the WHO, a . Falsified Medicine is a “Medical product that deliberately/fraudulently misrepresent their identity, composition or source”.. Multiple-Stakeholder Partnerships for Medicines Benefits in Moving Towards UHC. . Universal Health Coverage: Considerations in designing Medicines Benefits Policies and Programmes, . September . 28-29, 2014, Cape Town, South Africa . [INSERT DATE HERE]. [NAME OF PRESENTER]. [TITLE OF PRESENTER]. [COMPANY NAME]. Falsified medicines – a real problem. 2. The Pharmaceutical Journal, 5. th. June 2014. Why we need a Directive . Falsified products still being found in legitimate medicines supply chain – major risk to patient safety. [INSERT DATE HERE]. [NAME OF PRESENTER]. [TITLE OF PRESENTER]. [COMPANY NAME]. Falsified medicines – a real problem. 2. The Pharmaceutical Journal, 5. th. June 2014. Why we need a Directive . Falsified products still being found in legitimate medicines supply chain – major risk to patient safety. t. he PC’s visits to Limpopo and Mpumalanga Provinces. Presentation by the DPSA to the Portfolio Committee on Public Service and Administration, Planning Monitoring and Evaluation. 15 November 2017. [INSERT DATE HERE]. [NAME OF PRESENTER]. [TITLE OF PRESENTER]. [COMPANY NAME]. Falsified medicines – a real problem. 2. The Pharmaceutical Journal, 5. th. June 2014. Why we need a Directive . Falsified products still being found in legitimate medicines supply chain – major risk to patient safety. Scanning packs – what to look for Implementing the EU Falsified Medicines Directive in the UK [INSERT DATE HERE] [NAME OF PRESENTER] [TITLE OF PRESENTER] [COMPANY NAME] FMD – what the “right” packs look like The . HDA (formerly BAPW) . Who we are. Good Distribution Practice . HDA is a UK-wide representative trade association whose mission is to advance the interests and values of those member companies who provide .